Journal of Stem Cells and Regenerative Medicine,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 31, 2024
Osteoarthritis
(OA)
is
a
degenerative
disease
that
causes
chronic
pain
and
disability
worldwide.
This
mainly
caused
by
IL-1β
TNF-α,
which
lead
to
cartilage
degradation
inhibit
the
repair
capacity
of
damaged
cartilage.
Recent
studies
have
shown
amniotic
fluid
mesenchymal
stem
cells
(AF-MSCs)
secrete
proteins
can
effectively
help
in
treatment
OA.
However,
underlying
mechanism
still
unclear.
Therefore,
aim
this
study
was
investigate
effects
mechanisms
behind
healing
properties
AF-MSC
secretome
(AFS-se)
under
OA
conditions.
involved
growing
chondrocyte
progenitor
(CPCs)
traumatized
tissues
presence
cytokines
mimic
AFS-se
then
added
culture
medium
determine
its
effect
on
CPCs
Cell
migration,
endogenous
cell
outgrowth,
expression
chondrogenic
anabolic
genes,
NF-κB
MAPK
signaling
pathways
were
examined
study.
inhibited
inflammatory
TNF-α
significantly
reducing
ERK
phosphorylation
pathway
decreasing
downstream
proinflammatory
COX2
products.
The
impaired
recovered
their
ability
migrate,
injured
osteoarthritic
able
regrow
response
stimuli.
Additionally,
genes
such
as
Frontiers in Cell and Developmental Biology,
Journal Year:
2023,
Volume and Issue:
11
Published: June 23, 2023
Bone
healing
is
associated
with
many
orthopedic
conditions,
including
fractures
and
osteonecrosis,
arthritis,
metabolic
bone
disease,
tumors
periprosthetic
particle-associated
osteolysis.
How
to
effectively
promote
has
become
a
keen
topic
for
researchers.
The
role
of
macrophages
marrow
mesenchymal
stem
cells
(BMSCs)
in
gradually
come
light
the
development
concept
osteoimmunity.
Their
interaction
regulates
balance
between
inflammation
regeneration,
when
inflammatory
response
over-excited,
attenuated,
or
disturbed,
it
results
failure
healing.
Therefore,
an
in-depth
understanding
function
regeneration
relationship
two
could
provide
new
directions
This
paper
reviews
mechanism
significance
their
interaction.
Several
therapeutic
ideas
regulating
by
targeting
crosstalk
are
also
discussed.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
173, P. 116458 - 116458
Published: March 19, 2024
Osteoarthritis
(OA)
is
a
multifaceted
disease
characterized
by
imbalances
in
extracellular
matrix
metabolism,
chondrocyte
and
synoviocyte
senescence,
as
well
inflammatory
responses
mediated
macrophages.
Although
there
have
been
notable
advancements
pharmacological
surgical
interventions,
achieving
complete
remission
of
OA
remains
formidable
challenge,
oftentimes
accompanied
significant
side
effects.
Mesenchymal
stem
cells
(MSCs)
emerged
promising
avenue
for
treatment,
given
their
ability
to
differentiate
into
chondrocytes
facilitate
cartilage
repair,
thereby
mitigating
the
impact
an
microenvironment
induced
This
comprehensive
review
aims
provide
concise
overview
diverse
roles
played
MSCs
treatment
OA,
while
elucidating
underlying
mechanisms
behind
these
contributions.
Specifically,
include:
(a)
Promotion
regeneration;
(b)
Inhibition
degradation;
(c)
Attenuating
macrophage-induced
microenvironment;
(d)
Alleviation
pain.
Understanding
paramount
developing
novel
therapeutic
strategies.
By
harnessing
regenerative
potential
immunomodulatory
properties
MSCs,
it
may
be
possible
devise
more
effective
safer
approaches
managing
OA.
Further
research
clinical
studies
are
warranted
optimize
utilization
realize
full
field
therapeutics.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(15), P. 12282 - 12282
Published: July 31, 2023
Osteoarthritis
(OA)
is
characterized
by
degeneration
of
the
joint
cartilage,
inflammation,
and
a
change
in
chondrocyte
phenotype.
Inflammation
also
promotes
cell
hypertrophy
human
articular
chondrocytes
(HC-a)
activating
NF-κB
pathway.
Chondrocyte
inflammation
promote
extracellular
matrix
degradation
(ECM).
Chondrocytes
depend
on
Smad
signaling
to
control
regulate
as
well
maintain
ECM.
The
involvement
these
two
pathways
crucial
for
preserving
homeostasis
cartilage.
In
recent
years,
Polynucleotides
Highly
Purified
Technology
(PN-HPT)
has
emerged
promising
area
research
treatment
OA.
PN-HPT
involves
use
polynucleotide-based
agents
with
controlled
natural
origins
high
purification
levels.
this
study,
we
focused
evaluating
efficacy
specific
polynucleotide
sodium
agent,
known
CONJURAN,
which
derived
from
fish
sperm.
(PN),
are
physiologically
present
function
water-soluble
nucleic
acids
gel-like
property,
have
been
used
treat
patients
However,
mechanisms
underlying
effect
remain
unclear.
Therefore,
investigated
PN
an
OA
model
HC-a
cells
were
stimulated
interleukin-1β
(IL-1β)
or
without
treatment.
CCK-8
assay
was
assess
cytotoxic
effects
PN.
Furthermore,
enzyme-linked
immunosorbent
utilized
detect
MMP13
levels,
nitric
oxide
determine
inflammation.
anti-inflammatory
related
using
quantitative
PCR,
Western
blot
analysis,
immunofluorescence
examine
analyze
relative
markers.
inhibited
IL-1β
induced
destruction
genes
proteins
downregulating
expression
MMP3,
MMP13,
iNOS,
COX-2
while
increasing
aggrecan
(ACAN)
collagen
II
(COL2A1).
This
study
demonstrates,
first
time,
that
exerted
partially
inhibiting
pathway
Smad2/3
Based
our
findings,
can
potentially
serve
ACS Omega,
Journal Year:
2024,
Volume and Issue:
9(19), P. 21467 - 21483
Published: May 1, 2024
Osteoarthritis
(OA)
is
a
chronic
musculoskeletal
disorder
characterized
by
cartilage
degeneration
and
synovial
inflammation.
Paracrine
interactions
between
chondrocytes
macrophages
play
an
essential
role
in
the
onset
progression
of
OA.
In
this
study,
replicating
inflammatory
response
during
OA
pathogenesis,
were
treated
with
interleukin-1β
(IL-1β),
lipopolysaccharide
interferon-γ.
addition,
coculture
system
was
developed
to
simulate
biological
situation
joint.
we
examined
impact
hyaluronic
acid
(HA)
viscosupplement,
particularly
Hyruan
Plus,
on
macrophages.
Notably,
viscosupplement
has
demonstrated
promising
outcomes
reducing
inflammation;
however,
underlying
mechanism
action
remains
elusive.
The
attenuated
inflammation,
showing
inhibitory
effect
nitric
oxide
production,
downregulating
proinflammatory
cytokines
such
as
matrix
metalloproteinases
(MMP13
MMP3),
upregulating
expression
levels
type
II
collagen
aggrecan
chondrocytes.
HA
also
reduced
level
IL-1β,
TNF-α,
IL-6
macrophages,
exerted
overall
protective
partially
suppressing
MAPK
pathway
p65/NF-κB
signaling
Therefore,
shows
potential
for
treating
arthritic
joints.
ACS Biomaterials Science & Engineering,
Journal Year:
2024,
Volume and Issue:
10(5), P. 3355 - 3377
Published: April 2, 2024
An
imbalance
between
M1
and
M2
macrophage
polarization
is
critical
in
osteoarthritis
(OA)
development.
We
investigated
the
effect
of
macrophage-derived
extracellular
vesicles
(M2-EVs)
to
reprogramme
macrophages
from
phenotype
for
OA
treatment.
mouse
models
were
treated
with
M2-EVs.
Proteomic
analysis
was
performed
evaluate
vitro.
The
as
follows:
destabilization
medial
meniscus
(DMM)
surgery-induced
collagenase-induced
(CIOA).
Hyaluronic
acid
(HA)
used
deliver
M2-EVs
decreased
accumulation,
repolarized
phenotype,
mitigated
synovitis,
reduced
cartilage
degradation,
alleviated
subchondral
bone
damage,
improved
gait
abnormalities
CIOA
DMM
models.
Moreover,
HA
increased
retention
time
enhanced
efficiency
Furthermore,
proteomic
demonstrated
that
exhibited
a
reprogramming
ability
similar
IL-4,
pathways
might
be
NOD-like
receptor
(NLR),
TNF,
NF-κB,
Toll-like
(TLR)
signaling
pathways.
reprogrammed
which
resulted
beneficial
effects
on
attenuation
severity.
In
summary,
our
study
indicated
M2-EV-guided
promising
treatment
strategy
OA.
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2024,
Volume and Issue:
397(10), P. 8023 - 8041
Published: May 22, 2024
Diabetic
cardiomyopathy
(DCM)
is
a
serious
common
complication
of
diabetes.
Unfortunately,
there
no
satisfied
treatment
for
those
patients
and
more
studies
are
in
critical
need
to
cure
them.
Therefore,
we
aimed
carry
out
our
current
research
explore
the
role
two
novel
therapeutic
approaches:
one
biological
drug
block
inflammatory
signaling
IL
1beta
(IL1β)
axis,
namely,
anakinra;
other
provision
anti-inflammatory
regenerative
stem
cells.
Wistar
male
rats
were
allocated
into
four
groups:
control
group:
type
2
diabetes
mellitus
(DM)
induced
by
6-week
high-fat
diet
(HFD)
followed
single-dose
streptozotocin
(STZ)
35
mg/kg
i.p.,
then
into:
DM:
untreated;
DM
BM-MSCs:
received
single
dose
BM-MSCs
(1
×
10
Journal of Orthopaedic Surgery and Research,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: Jan. 2, 2025
There
is
currently
no
definitive
treatment
for
osteoarthritis.
We
examined
the
therapeutic
effects
and
underlying
mechanisms
of
platelet-rich
plasma
(PRP)
adipose-derived
mesenchymal
stem
cells
(ADSCs),
individually
or
in
combination,
a
rat
model
anterior
cruciate
ligament-induced
degenerative
osteoarthritis
(OA)
knee.
This
study
seeks
to
advance
clinical
approaches
OA
treatment.
Eight-
nine-week-old
male
Sprague-Dawley
(SD)
rats
were
randomly
assigned
two
groups:
(1)
normal
control
group
(Group
A)
(2)
group.
The
received
underwent
was
further
subdivided
into
six
Group
B
(an
injury
group),
C
(high-dose
ADSCs),
D
(PRP
combined
with
high-dose
E
(low-dose
F
low-dose
G
alone).
PRP
and/or
ADSCs
administered
via
intra-articular
injection
on
Days
7,
37,
67
post-surgery.
Daily
observations
recorded
activity
levels
behavior,
while
weight
changes
monitored
weekly.
Digital
radiography
(DR)
conducted
30,
60,
90
post-surgery
assess
joint
surface
contour
alterations.
Histopathological
examination
inflammatory
factor
analysis
performed
cartilage
synovial
tissue.
No
abnormal
reactions
observed
any
rats,
body
weights
increased
as
expected
(P
>
0.05).
Significant
differences
knee
swelling
rates
Wakitani
scores
between
Groups
A
<
0.01).
Knee
also
differed
significantly
C–G
decreased
60
C–G.
TNF-α
IL-1β
expression
higher
compared
Expression
these
genes
lower
than
Repeated
injections
alleviated
inflammation
pain,
promoted
tissue
repair,
modulated
immune
responses
surgically
induced
OA.
combination
demonstrated
enhanced
efficacy,
suggesting
its
potential
option
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 7, 2025
Exosomes
(EXOs)
as
a
targeted
cell-free
therapy
could
offer
new
therapeutic
strategy
for
immune-mediated
inflammatory
diseases,
due
to
their
stability
and
ease
of
storage
handling.
This
study
focused
on
exosomes
derived
from
stem
cells
human
exfoliated
deciduous
teeth
(SHED-MSC-EXOs)
role
in
managing
the
balance
immunoregulatory
macromolecules
that
play
underlying
mechanisms
THP-1-derived
M0/M1
macrophage
cells.
Flow
cytometry
confirmed
expression
CD14,
CD68,
CD80,
CD86
markers
these
macrophages.
Following
morphological
survival
assessments,
culture
supernatants
SHED-MSCs
were
used
isolate
exosomes.
Once
verified,
Calcein
AM-labeled
EXOs
introduced
The
assessed
by
analyzing
surface
markers,
cytokine
production,
pro-
antioxidant
activity.
Macrophages
treated
with
exhibited
immunomodulatory
effects
akin
those
dexamethasone.
levels
anti-inflammatory
including
CD206,
Arg-1,
IL-10,
TGF-β,
TAC,
CAT,
SOD,
which
act
immunosuppressive
macromolecules,
elevated.
In
contrast,
there
was
reduction
pro-inflammatory
pro-oxidant
CD81,
IL-6R,
IL-12,
TNF-α,
MDA,
NO,
immunostimulatory
(P
<
0.05).
findings
suggest
SHED-MSC
can
skew
macrophages
M2
phenotype
inhibit
M1
polarization.
These
nanovesicles,
distinct
physical
properties
ability
penetrate
target
cells,
may
prove
beneficial
conditions
involving
depletion
macrophage-induced
potentially
aiding
inflammation
tissue
injury.